Literature DB >> 21821860

Epigenomic profiling in polycythaemia vera and essential thrombocythaemia shows low levels of aberrant DNA methylation.

S Barrio1, M Gallardo, E Albizua, A Jimenez, I Rapado, R Ayala, F Gilsanz, J I Martin-Subero, J Martinez-Lopez.   

Abstract

AIMS: The purpose of this study was to compare the DNA-methylation signature in classic chronic Philadelphia negative myeloproliferative neoplasms (MPN), polycythaemia vera (PV) and essential thrombocythaemia (ET), in order to obtain a global insight into DNA-methylation changes associated with these malignancies.
METHODS: Thirty-five MPN samples from 11 ET JAK2 V617F, 12 ET JAK2 wild type (WT) and 12 PV JAK2 V617F patients as well as 12 from healthy donors were analysed. DNA samples extracted from whole peripheral blood were hybridised to the 'HumanMethylation27 DNA Analysis BeadChip.'
RESULTS: All groups showed a very homogeneous methylation pattern. Only the ZNF577 gene showed a differential methylation profile between PV JAK2 V617F positive and controls. This aberrant methylation was correlated with a differential gene expression of ZNF577. No aberrant hypermethylation was found in the SOCS-1 and SOCS-3 genes.
CONCLUSIONS: According to our results, an aberrant methylation pattern does not seem to play a crucial role in MPN pathogenesis; nor does it justify phenotypical differences between PV and ET.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21821860     DOI: 10.1136/jclinpath-2011-200175

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Aberrant DNA methylation profile of chronic and transformed classic Philadelphia-negative myeloproliferative neoplasms.

Authors:  Cristina Pérez; Marien Pascual; José Ignacio Martín-Subero; Beatriz Bellosillo; Victor Segura; Eric Delabesse; Sara Álvarez; María José Larrayoz; José Rifón; Juan Cruz Cigudosa; Carles Besses; María José Calasanz; Nicholas C P Cross; Felipe Prósper; Xabier Agirre
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

2.  A critical appraisal of tools available for monitoring epigenetic changes in clinical samples from patients with myeloid malignancies.

Authors:  Kirsten Grønbæk; Carsten Müller-Tidow; Giovanni Perini; Sören Lehmann; Marianne Bach Treppendahl; Ken Mills; Christoph Plass; Brigitte Schlegelberger
Journal:  Haematologica       Date:  2012-04-04       Impact factor: 9.941

3.  Methylation profiling of serum DNA from hepatocellular carcinoma patients using an Infinium Human Methylation 450 BeadChip.

Authors:  Pengjun Zhang; Xinyu Wen; Feng Gu; Xinxin Deng; Juan Li; Jin Dong; Jiao Jiao; Yaping Tian
Journal:  Hepatol Int       Date:  2013-09-03       Impact factor: 6.047

4.  Cannabinoid-induced enhanced interaction and protein levels of serotonin 5-HT(2A) and dopamine D₂ receptors in rat prefrontal cortex.

Authors:  Jade M Franklin; Gonzalo A Carrasco
Journal:  J Psychopharmacol       Date:  2012-07-11       Impact factor: 4.153

5.  Role of MXD3 in proliferation of DAOY human medulloblastoma cells.

Authors:  Gustavo A Barisone; Tin Ngo; Martin Tran; Daniel Cortes; Mehdi H Shahi; Tuong-Vi Nguyen; Daniel Perez-Lanza; Wanna Matayasuwan; Elva Díaz
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

6.  Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.

Authors:  Baidehi Basu; Joyeeta Chakraborty; Aditi Chandra; Atul Katarkar; Jadav Ritesh Kumar Baldevbhai; Debjit Dhar Chowdhury; Jay Gopal Ray; Keya Chaudhuri; Raghunath Chatterjee
Journal:  Clin Epigenetics       Date:  2017-02-03       Impact factor: 6.551

Review 7.  JAK2 mutants (e.g., JAK2V617F) and their importance as drug targets in myeloproliferative neoplasms.

Authors:  Karoline Gäbler; Iris Behrmann; Claude Haan
Journal:  JAKSTAT       Date:  2013-05-14

8.  Methylation profiling of SOCS1, SOCS2, SOCS3, CISH and SHP1 in Philadelphia-negative myeloproliferative neoplasm.

Authors:  Min Yue Zhang; Tsz Kin Fung; Fang Yuan Chen; Chor Sang Chim
Journal:  J Cell Mol Med       Date:  2013-10-16       Impact factor: 5.310

9.  miR-203 and miR-221 regulate SOCS1 and SOCS3 in essential thrombocythemia.

Authors:  A Navarro; S Pairet; A Álvarez-Larrán; A Pons; G Ferrer; R Longarón; C Fernández-Rodríguez; L Camacho; M Monzó; C Besses; B Bellosillo
Journal:  Blood Cancer J       Date:  2016-03-18       Impact factor: 11.037

10.  Novel regional age-associated DNA methylation changes within human common disease-associated loci.

Authors:  Christopher G Bell; Yudong Xia; Wei Yuan; Fei Gao; Kirsten Ward; Leonie Roos; Massimo Mangino; Pirro G Hysi; Jordana Bell; Jun Wang; Timothy D Spector
Journal:  Genome Biol       Date:  2016-09-23       Impact factor: 13.583

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.